Core Alternative ETF
CCOR - ETF AI Analysis
Top Page
Core Alternative ETF (CCOR)
CCOR’s rating suggests it is a solid, quality ETF, helped by major positions in companies like Alphabet and Microsoft, which benefit from strong financial performance and growth in AI and cloud services. Stable blue-chip holdings such as Johnson & Johnson and Exxon Mobil further support the fund, though weaker names like Air Products and Chemicals, which face profitability and cash flow challenges, slightly weigh on the overall picture. The main risk factor is that a meaningful portion of the fund is concentrated in a handful of large companies, so their performance has an outsized impact on the ETF.
CCOR vs. SPDR S&P 500 ETF (SPY)
- AUM
- 27.00M
- Region
- North America
- Expense Ratio
- 1.16%
- Beta
- -0.00
- Issuer
- Core Alternative
- Inception Date
- May 24, 2017
- Dividend Yield
- 0.91%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
CCOR Summary
Core Alternative ETF (CCOR) is a U.S.-focused fund that aims to cover the total stock market without tracking a specific index. It spreads investments across many sectors, including financials, health care, technology, energy, and more, giving you broad diversification in one holding. Well-known companies in the fund include Alphabet (Google), Microsoft, Johnson & Johnson, Exxon Mobil, and JPMorgan Chase. Someone might invest in CCOR to get wide exposure to different types of companies and potential long-term growth. A key risk is that its value can rise or fall with overall stock market swings.
How much will it cost me?
This ETF has an expense ratio of 1.16%, which means you’ll pay about $11.60 per year for every $1,000 invested. That’s higher than the average ETF because it’s more actively managed, using a specialized strategy rather than simply tracking a basic market index.
What would affect this ETF?
Because CCOR is broadly invested in U.S. stocks across many sectors, it can benefit from overall economic growth, strong technology and health care companies like Microsoft, Alphabet, and Johnson & Johnson, and stable demand for energy and financial services. On the negative side, rising interest rates, slower U.S. growth, tighter banking rules, or weaker energy prices could hurt its financial and energy holdings, while market downturns would likely weigh on the fund’s diversified portfolio as a whole.
CCOR Top 10 Holdings
CCOR is leaning on a mix of U.S. blue chips, with Exxon Mobil and Amgen doing much of the heavy lifting as their shares keep rising, giving the fund a strong energy and health care backbone. Emerson Electric and Johnson & Johnson are also pulling their weight with steady gains, adding industrial and defensive balance. On the other side, Alphabet has been lagging, and Morgan Stanley is losing steam, creating some drag from Big Tech and financials. Overall, the ETF is broadly diversified across sectors but still firmly anchored in large U.S. names.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 4.74% | $1.28M | $682.52B | 46.35% | 78Outperform | |
| Alphabet Class A | 4.26% | $1.15M | $3.63T | 6.17% | 85Outperform | |
| Microsoft | 4.19% | $1.13M | $3.88T | 4.09% | 79Outperform | |
| Emerson Electric Company | 3.79% | $1.02M | $91.57B | 29.52% | 76Outperform | |
| Exxon Mobil | 3.78% | $1.02M | $692.57B | 43.61% | 74Outperform | |
| Amgen | 3.66% | $989.12K | $252.64B | 38.59% | 77Outperform | |
| Air Products and Chemicals | 3.58% | $966.66K | $70.41B | 20.34% | 46Neutral | |
| JPMorgan Chase | 3.49% | $943.98K | $910.40B | 11.86% | 72Outperform | |
| Morgan Stanley | 3.47% | $937.80K | $295.68B | 15.12% | 76Outperform |
CCOR Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CCOR, the sentiment is Positive. The current price of 27.57 is above the 20-day moving average (MA) of 26.88, above the 50-day MA of 26.10, and above the 200-day MA of 26.09, indicating a bullish trend. The MACD of 0.47 indicates Negative momentum. The RSI at 65.97 is Neutral, neither overbought nor oversold. The STOCH value of 52.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CCOR.
CCOR Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $27.57 | $29.00(5.18% Upside) | $27.00M | 1.16% | 74Outperform | |
| $34.37 | $38.05(10.70% Upside) | $98.92M | 0.87% | 71Outperform | |
| $37.80 | $42.76(13.12% Upside) | $93.99M | 0.85% | 69Neutral | |
| $31.98 | $36.55(14.29% Upside) | $89.68M | 0.75% | 70Outperform | |
| $22.23 | $28.86(29.86% Upside) | $90.01M | 0.59% | 74Outperform | |
| $35.70 | $42.70(19.60% Upside) | $86.06M | 0.65% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CCOR | Core Alternative ETF | 27.57 | 1.75 | 6.76% | |
| BAMD | Brookstone Dividend Stock ETF | 34.37 | 5.55 | 19.25% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 37.80 | 5.96 | 18.72% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.98 | 4.65 | 17.00% | |
| PFOE | Pathfinder Focused Opportunities ETF | 22.23 | -2.63 | -10.58% | |
| VAMO | Cambria Value & Momentum ETF | 35.70 | 3.87 | 12.16% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
